The CADET Trials are investigating whether a commonly prescribed blood pressure medication could provide a much-needed treatment alternative for adults with severe depression.

Candesartan is a well-tolerated group of medications widely used to treat high blood pressure and heart failure and could help people with depression in both major depressive disorder and bipolar disorder.

Researchers are looking for people in Queensland and Victoria to take part in the 16-week trial to see if a daily dose of candesartan, in addition to usual treatment, reduces symptoms of depression and improves general quality of life.

To discuss the potential impacts of this study, we speak with Professor Michael Berk, Director of Deakin’s Institute for Mental and Physical Health and Clinical Translation (IMPACT) and Research Assistant Paul Cortissos.

Check out our other JOY Podcasts for more on LGBTIQ+ health and wellbeing at joy.org.au/wellwellwell.

If there’s something you’d like us to explore on the show, send through ideas or questions at [email protected]

Find out more about LGBTIQ+ services and events in Victoria at thorneharbour.org and in South Australia at samesh.org.au.